Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Ocaratuzumab |
Trade Name | |
Synonyms | AME-133v|AME133v|AME 133v|LY2469298|LY 2469298|LY-2469298 |
Drug Descriptions |
Ocaratuzumab (AME-133v) is a monoclonal antibody directed against CD20, which may result in antibody-dependent cell-mediated cytotoxicity and decreased tumor cell growth (PMID: 22223529, PMID: 30089638). |
DrugClasses | CD20 Antibody 21 |
CAS Registry Number | 1169956-08-4 |
NCIT ID | C2524 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ocaratuzumab | Ocaratuzumab | 0 | 0 |